In a historic milestone, SUANFARMA has established a vital collaboration with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients, with the central objective of introducing generic pharmaceutical ingredients to the market, especially for treating infectious diseases.
This strategic alliance focuses on developing new manufacturing processes, using cutting-edge technologies and applying green chemistry, in order to produce high-quality medications at more affordable prices.
SUANFARMA's innovative technology, which is based on Flow Chemistry, promises to solve the global shortage of antibacterial products supply, fundamental for public health. Reyoung Pharmaceutical, with its decades of experience in exporting products worldwide, perfectly complements SUANFARMA in this venture.
Both companies have agreed to a strategic cooperation for the production of pharmaceutical active ingredients in the field of anti-infectives and antibacterials, recognizing the importance of ensuring the supply of these medications at a time of uncertainty in the pharmaceutical supply chain globally.
SUANFARMA is committed to both health and environmental sustainability.
The company focuses its efforts on developing technologies to maximize efficiency in its processes and prioritizes the adoption of environmentally friendly practices. The Flow Chemistry technology they have developed reduces the use of raw materials and environmental impact, while improving safety in drug synthesis.
Both organizations express their enthusiasm for this transformative collaboration that will unite innovation with exceptional product delivery. This strategic agreement marks the beginning of a promising collaboration that will seek to offer superior products to patients.
With information from: PMFarma.
Receive all industry news in our weekly Newsletter Scientific Dialectics.